Novanta Inc. (NASDAQ:NOVT) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
Novanta Inc. (the Company) will hold a conference call on June 6,
2017 to discuss the World of Medicine transaction. A copy of the
Companys conference call presentation is attached hereto as
Exhibit 99.1 and is also available on the Companys website,
www.novanta.com, in the Investor Relations section.
The information contained in Exhibit 99.1 is furnished under this
Item 7.01 and shall not be deemed filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, or
incorporated by reference in any filing thereunder or under the
Securities Action of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits:
|
99.1 |
Announcement of World of Medicine Acquisition, June 2017. |
About Novanta Inc. (NASDAQ:NOVT)
Novanta Inc., formerly GSI Group Inc., designs, develops, manufactures and sells photonic and motion control components and subsystems. The Company offers its products to original equipment manufacturers in the medical equipment and industrial technology markets. Its segments include Laser Products, Vision Technologies and Precision Motion. The Laser Products segment designs, manufactures and markets photonics-based solutions, including carbon dioxide laser sources, laser scanning and laser beam delivery products. The Vision Technologies segment designs, manufactures and markets a range of medical grade technologies, including visualization solutions, imaging informatics products, radio frequency identification technologies, thermal printers, and light and color measurement instrumentation. The Precision Motion segment designs, manufactures and markets optical encoders, precision motors and other motion control technology, air bearing spindles and precision machined components.
